Takao Hensch wins Mortimer D. Sackler, MD Prize

Takao Hensch, professor of neurology at Harvard Medical School's Boston Children's Hospital, has won the Mortimer D. Sackler, MD Prize for Distinguished Achievement in Developmental Psychobiology.

Women with healthy BMI may have higher risk of breast cancer

Women with a healthy body mass index may be at risk of breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, Weill Cornell Medicine research finds.

NIH allergist awarded Drukier Prize by Weill Cornell Medicine

Dr. Joshua Milner, an allergist and immunologist who has made key discoveries into the origin of previously unidentified disorders that affect children, has been awarded the Drukier Prize.

Brain stents improve head pressure and vision loss

Weill Cornell Medicine researchers find that brain stents successfully treat symptoms of Idiopathic intracranial hypertension such as head pressure and vision loss.

Three-pronged approach is key to precision medicine

Combining genetic information from tumor cells with 3-D cell cultures grown from these tumors, and rapidly screening approved drugs, can identify the best treatment approaches in patients.

Weill Cornell Medicine celebrates Match Day 2017

Weill Cornell Medicine celebrated one of its best Match Days ever March 17, with 100 percent of the graduating medical students matching to residency positions - the next three to seven years of their medical careers.

Delirium in critically ill children admitted to hospitals is common

One out of every four children admitted to intensive care units for critical illness develops delirium, according to an international study led by Weill Cornell Medicine investigators.

Cornell ranked among best in U.S. News grad school rankings

The 2018 U.S. News & World Report ranking of graduate schools is out, and Cornell has again landed in the top 10 for English and engineering programs.

Gene mutation found to drive prostate cancer subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists.